Drug

D0334 | Cupric oxide

Molecular Formula CuO
Molecular Weight 79.55
Structure
State solid
Clearance No pharmacokinetic data available.
Volume of distribution Following exposure to cupric oxide aerosols containing 50-80 mg/m^3 in rats, particles were found in plasma 6 hours post-exposure and copper oxide was also observed in the proximal convoluted tubules of the kidney [L2422].
Route of elimination Copper undergoes biliary excretion [L2422].
Protein binding Once dissociated, copper is known to bind to serum albumin, ceruloplasmin, and other low-molecular weight complexes [L2422].
Half life No pharmacokinetic data available.
Absorption Following oral administration, copper is mainly absorbed through the gastrointestinal tract from the stomach, duodenum, and jejunum. All other intakes of copper (inhalation and dermal) are insignificant in comparison to the oral route. The bioavailability of copper from cupric oxide depends on the solubilization of the oxide in the gastrointestinal tract [L2437]. According to studies on cattle and swine, copper oxide displays low absorption rate and high excretion rate [L2422]. In rats exposed to aerosols containing 50-80 mg/m^3, pulmonary uptake of copper oxide occurred [L2422].


  • 1344-70-3 CB 250 CHEBI:75955
    CHEMBL1909057 Copper(II) oxide 325 mesh powder Copper(II) oxide on alumina
    Cu(II) oxide Cupric oxide,granular Cupricoxide
    Cuprum oxydatum nigrum DB11134 DTXSID5034488
    EINECS 215-706-6 Epitope ID:190360 KKCXRELNMOYFLS-UHFFFAOYSA-N
    Q421787 SC-79684

    DrugBank Name Cupric oxide
    DrugBank DB11134
    CAS Number 10025-82-8, 1317-38-0, 1344-70-3
    PubChem Compound 164827
    PubChem.Substance 347827912
    ChEBI 75955
    ChemSpider 144499
    Wikipedia Copper(II)_oxide
    DPD 7126|582